# Efficacy and Acceptability of Two Lubricant Eye Drops

> **NCT00756678** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 51 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** Lubricant Eye Drops (Optive™)
- **DRUG:** Lubricating Eye Drops (blink® Tears)

## Key facts

- **NCT ID:** NCT00756678
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2011-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00756678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00756678, "Efficacy and Acceptability of Two Lubricant Eye Drops". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00756678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*